SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Panjon - Quaterly Results

25 May 2023 Evaluate
The sales slipped to Rs. 13.02 millions for the March 2023 quarter as against Rs. 15.76 millions during the year-ago period.The Net Loss for the quarter ended March 2023 is Rs. -0.05 millions as compared to Net Loss of Rs. -41.52 millions of corresponding quarter ended March 2022 Operating profit Margin for the quarter ended March 2023 improved to 1.30% as compared to -41.04% of corresponding quarter ended March 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 13.02 15.76 -17.39 60.91 84.32 -27.76 60.91 84.32 -27.76
Other Income 2.42 0.52 365.38 3.82 2.97 28.62 3.82 2.97 28.62
PBIDT 1.30 -41.04 -103.17 3.75 -37.46 -110.01 3.75 -37.46 -110.01
Interest 0.20 0.15 33.33 0.47 0.64 -26.56 0.47 0.64 -26.56
PBDT 1.10 -41.19 -102.67 3.28 -38.10 -108.61 3.28 -38.10 -108.61
Depreciation 1.15 0.33 248.48 2.11 2.03 3.94 2.11 2.03 3.94
PBT -0.05 -41.52 -99.88 1.17 -40.13 -102.92 1.17 -40.13 -102.92
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.05 -41.52 -99.88 1.17 -40.13 -102.92 1.17 -40.13 -102.92
Equity 154.99 154.99 0.00 154.99 154.99 0.00 154.99 154.99 0.00
PBIDTM(%) 9.98 -260.41 -103.83 6.16 -44.43 -113.86 6.16 -44.43 -113.86

Panjon Share Price

24.61 -0.52 (-2.07%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×